A Study to Asses Wellness Using a Brain Sensing Device on Physicians
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04743973 |
|
Recruitment Status :
Recruiting
First Posted : February 8, 2021
Last Update Posted : September 5, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Stress, Emotional Sleep Quality of Life | Device: Muse S™ Headband system | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 20 participants |
| Allocation: | N/A |
| Intervention Model: | Single Group Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Supportive Care |
| Official Title: | A Feasibility Study Evaluating Mindfulness-Based Intervention Assessing A Wearable Wellness Brain Sensing Device (Muse-S) in Practicing Physicians |
| Actual Study Start Date : | August 15, 2021 |
| Estimated Primary Completion Date : | August 15, 2022 |
| Estimated Study Completion Date : | August 15, 2023 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Practicing Physicians
Practicing physicians at Mayo Clinic caring for patients during the COVID 19 pandemic will receive the Muse S™ Headband system, and will be asked to utilize it at least 4 times per week for a minimum of 10 minutes each time over a period of 3 months (12 weeks).
|
Device: Muse S™ Headband system
Brain sensing headband that measures brain activity by detecting electrical impulses created by the brain. |
- Frequency adherence to intervention [ Time Frame: 3 months ]Summarizing frequency subjects use intervention during active study participation
- Duration adherence to intervention [ Time Frame: 3 months ]Summarizing duration of time subjects use intervention during active study participation
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- 18 years of age or older at time of consent
- Practicing Physicians at Mayo Clinic
- Not pregnant by subject self-report at time of consent
- Have the ability to provide informed consent
- Have the ability to complete all aspects of this trial
- Have access to a smart phone or tablet device
- Have no contraindicating comorbid health condition which would interfere with the proper use of the Muse-S™ system, as determined by the clinical investigators
Exclusion Criteria:
- Used an investigational drug within the past 30 days
- Currently (within the past 3 weeks) been practicing mindfulness training on a weekly/regular basis
- Currently (within 3 weeks) been enrolled in another clinical or research program (e.g. CAM) which intervenes on the patients' QOL, or stress
- An unstable medical or mental health condition as determined by the physician investigator
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04743973
| Contact: Shawn Fokken, CCRP | (507) 293-2740 | GIMRESEARCHSTUDIES@Mayo.edu |
| United States, Minnesota | |
| Mayo Clinic in Rochester | Recruiting |
| Rochester, Minnesota, United States, 55905 | |
| Contact: Shawn Fokken, CCRP 507-293-2740 GIMRESEARCHSTUDIES@mayo.edu | |
| Principal Investigator: | Ivana T Croghan, PhD | Mayo Clinic |
| Responsible Party: | Ivana Croghan, Principal Investigator, Mayo Clinic |
| ClinicalTrials.gov Identifier: | NCT04743973 |
| Other Study ID Numbers: |
20-007207 |
| First Posted: | February 8, 2021 Key Record Dates |
| Last Update Posted: | September 5, 2021 |
| Last Verified: | September 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | Yes |
|
mindfulness Wellness |

